- Home
- OPY vs EMBC Comparison
OPY vs EMBC Comparison
Compare OPY & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPY
- EMBC
- Stock Information
- Founded
- OPY 1881
- EMBC 1924
- Country
- OPY United States
- EMBC United States
- Employees
- OPY N/A
- EMBC N/A
- Industry
- OPY Investment Bankers/Brokers/Service
- EMBC Medical/Dental Instruments
- Sector
- OPY Finance
- EMBC Health Care
- Exchange
- OPY Nasdaq
- EMBC Nasdaq
- Market Cap
- OPY 666.7M
- EMBC 753.0M
- IPO Year
- OPY N/A
- EMBC N/A
- Fundamental
- Price
- OPY $63.44
- EMBC $20.10
- Analyst Decision
- OPY
- EMBC Buy
- Analyst Count
- OPY 0
- EMBC 2
- Target Price
- OPY N/A
- EMBC $19.00
- AVG Volume (30 Days)
- OPY 22.5K
- EMBC 425.7K
- Earning Date
- OPY 01-24-2025
- EMBC 02-07-2025
- Dividend Yield
- OPY 1.15%
- EMBC 3.06%
- EPS Growth
- OPY 83.00
- EMBC 9.84
- EPS
- OPY 6.42
- EMBC 1.34
- Revenue
- OPY $1,280,442,000.00
- EMBC $1,123,100,000.00
- Revenue This Year
- OPY N/A
- EMBC $0.26
- Revenue Next Year
- OPY N/A
- EMBC $1.24
- P/E Ratio
- OPY $9.82
- EMBC $14.72
- Revenue Growth
- OPY 7.32
- EMBC 0.21
- 52 Week Low
- OPY $36.93
- EMBC $9.93
- 52 Week High
- OPY $70.25
- EMBC $21.48
- Technical
- Relative Strength Index (RSI)
- OPY 51.98
- EMBC 54.30
- Support Level
- OPY $61.76
- EMBC $19.17
- Resistance Level
- OPY $65.70
- EMBC $21.23
- Average True Range (ATR)
- OPY 1.54
- EMBC 0.81
- MACD
- OPY -0.28
- EMBC -0.23
- Stochastic Oscillator
- OPY 42.52
- EMBC 45.15
About OPY Oppenheimer Holdings Inc. (DE)
Oppenheimer Holdings Inc conducts activities in the securities industry. The company is involved in retail securities brokerage, investment banking (both corporate and public finance), institutional sales and trading, market-making, research, trust services, and investment advisory and asset management services. The company has three segments: private client, asset management, and capital markets. The Private Client segment, commissions and a proportionate amount of fee income earned on assets under management ("AUM"), net interest earnings on client margin loans and cash balances, fees from money market funds, and custodian fees. The company generates the majority of its revenue from the Americas, with the rest from Europe, the Middle East, and Asia.
About EMBC Embecta Corp.
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.